KARAM MOUNZER: Open Payments
NPI 1265571152 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116,765 in 166 payments from 7 companies in 2025. Trend: 2023 $81,872 · 2024 $92,768 · 2025 $116,765
Speaker / faculty: $88,928Consulting: $13,910Travel & lodging: $6,845Food & beverage: $4,482Honoraria: $2,600
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 81 | $58,914 |
| ViiV Healthcare Company | 63 | $48,781 |
| Merck Sharp & Dohme LLC | 11 | $6,263 |
| Theratechnologies Inc. | 8 | $2,736 |
| ABBVIE INC. | 1 | $27 |
| Indivior Inc. | 1 | $26 |
| EMD Serono, Inc. | 1 | $19 |
Products named: RUKOBIA, Yeztugo, Biktarvy, DOVATO, EGRIFTA, Sunlenca, Descovy, DELSTRIGO.
Industry payments across PA — which companies pay providers there.
